Study on the Molecular Immunology Control between Type I and II Schizophrenics
Download as PDF
Wan Feng Li
Objective To explore the reference value of molecular immunological detection in the clinical diagnosis and treatment of type I and II schizophrenics. Methods 86 type I and II schizophrenics admitted and treated in our hospital from February 2015 to January 2017, together with 45 healthy subjects receiving molecular immunological detection at the same period were treated as the objects of study. They were divided into group I (n=41), group II (n=45) and control group (n=45). The molecular immunological detection results in each group of subjects were compared. Results Compared with control group, IgG and C4 levels in group I were remarkably higher, while IgM level was notably lower; meanwhile, IgA, IgM, IgG and C4 levels in group II were evidently higher. Compared with group I, IgM level in group II was distinctly higher, with the difference being statistically significant (P<0.05). The prognostic recovery effect in group I was superior to that in group II after treatment (P<0.05). Conclusion Molecular immunological detection results have certain reference value to the clinical diagnosis and treatment for type I and II schizophrenics.
Type I, Type II, Schizophrenia.